Labs / Assays & in vitro testing
Immuneoncia
Yongin, South Korea · immuneoncia.com
GLP · GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
ImmuneOncia is a clinical-stage biopharmaceutical company developing immuno-oncology drugs for cancer treatment. It focuses on antibodies that target T cells and macrophages, with operations in Yongin-si and Seoul, Republic of Korea.
Their website has a general contact form; we send your quote request through it.
What they offer
Immuno-oncology drug development
Develops immuno-oncology therapeutics for cancer treatment, including antibody-based programs and follow-on modalities.
Pipeline development
Advances internal pipeline programs such as IMC-001, IMC-002, and IMC-201.
Antibody engineering
Uses antibody engineering expertise to support drug development.
What they work on
- Modalities
- Antibody, ADC, Viral vector, LNP / formulation
- Species and models
- CHO cells, Insect cells
- Therapeutic areas
- cancer, immuno-oncology
- Sites
- Yongin-si, Gyeonggi-do, Republic of Korea · Seoul, Republic of Korea
- Serves
- global
- Address
- 05w Rd͙I? rMߏ0r:._V7opJD.R2Rϥ;Wu4Dw$)ugt3JrPzT8Rd : ؔQHrѱ2Q9\8
- Founded
- 2016
Similar labs. Aurora Biolabs, Invenra, Pavonis Diagnostics, Asimov
Found in a contract services directory. Listing built from immuneoncia.com. Work here? Claim this listing.